Tokyo, Japan

Kenji Tsunoda


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Saitama, JP (1988)
  • Urawa, JP (1998)
  • Tokyo, JP (1999 - 2001)

Company Filing History:


Years Active: 1988-2001

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kenji Tsunoda: Innovator in Pharmaceutical Advancements

Introduction

Kenji Tsunoda, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of seven patents. His innovative spirit and dedication to enhancing drug formulations have positioned him as a valuable asset in the industry.

Latest Patents

One of Kenji's latest patents focuses on a suspension of sparingly water-soluble acidic drugs, specifically targeting nonsteroidal anti-inflammatory analgesics. This formulation is noteworthy for its stability over prolonged periods and enhanced dissolvability. The suspension, which maintains a pH value between 2 and 5, comprises a sparingly water-soluble acidic drug with an average particle size ranging from 1 to 15 micrometers. It also includes a polyglycerol fatty acid ester, a water-soluble polyhydric alcohol, and water, optionally supplemented with an inorganic powder of similar particle size. Notably, his process emphasizes an innovative pulverization and dispersion method using a specialized pulverizer with interlocked main and layshafts.

Additionally, Kenji has developed remedies and preventive solutions for hyperlipemia, showcasing his commitment to addressing urgent health issues through innovative pharmaceutical solutions.

Career Highlights

Kenji Tsunoda is affiliated with Taisho Pharmaceutical Co., Ltd., where he plays a critical role in the research and development of new medicinal products. His expertise in formulating effective drug suspensions has greatly contributed to the advancement of pharmaceutical technologies.

Collaborations

Throughout his career, Kenji has collaborated with notable coworkers such as Hideaki Kitajima and Kazuo Hasegawa. These partnerships have fostered an environment ripe for innovation, allowing for the combination of their expertise in creating impactful pharmaceutical solutions.

Conclusion

With a strong foundation of patents and a collaborative spirit, Kenji Tsunoda stands as a leading inventor in the pharmaceutical industry. His contributions not only enhance drug formulations but also pave the way for future innovations in healthcare. Through his work at Taisho Pharmaceutical Co., Ltd., Kenji continues to push the boundaries of pharmaceutical science, impacting the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…